VEGF induces ascites in ovarian cancer patients via increasing peritoneal permeability by downregulation of Claudin 5

Gynecologic Oncology

Volumn 127, Issue 1, 2012, Pages 210-216

  Herr, Daniel ^a   Sallmann, Alexandra ^a   Bekes, Inga ^a   Konrad, Regina ^a   Holzheu, Iris ^a   Kreienberg, Rolf ^a   Wulff, Christine ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Ascites; Claudin 5; Ovarian cancer; Permeability

Indexed keywords

CLAUDIN 5; VASCULOTROPIN;

ARTICLE; ASCITES; CANCER CELL CULTURE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CANCER; PERITONEAL BIOPSY; PERITONEAL ENDOTHELIAL PERMEABILITY; PERMEABILITY; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ASCITES; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; CLAUDIN-5; COCULTURE TECHNIQUES; DOWN-REGULATION; FEMALE; GENE EXPRESSION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; OVARIAN NEOPLASMS; PERITONEAL CAVITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84865680246     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.05.002     Document Type: Article

References (35)

1. A.A. Ayantunde, and S.L. Parsons Pattern and prognostic factors in patients with malignant ascites: a retrospective study Ann Oncol 18 2007 945 949
2. A. Ayhan, S. Guven, E.S. Guven, and T. Kucukali Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors? Acta Obstet Gynecol Scand 86 2007 484 490
3. M.H. Cheng, M.S. Yen, K.C. Chao, B.C. Sheu, and P.H. Wang Differential diagnosis of gynecologic organ-related diseases in women presenting with ascites Taiwan J Obstet Gynecol 47 2008 384 390
4. R.N. Garrison, L.D. Kaelin, R.H. Galloway, and L.S. Heuser Malignant ascites. Clinical and experimental observations Ann Surg 203 1986 644 651
5. E. Dejana Endothelial cell-cell junctions: happy together Nat Rev Mol Cell Biol 5 2004 261 270
6. G. Bazzoni, and E. Dejana Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis Physiol Rev 84 2004 869 901
7. A. Walz, C. Keck, H. Weber, C. Kissel, and D. Pietrowski Effects of luteinizing hormone and human chorionic gonadotropin on corpus luteum cells in a spheroid cell culture system Mol Reprod Dev 72 2005 98 104
8. Herr D, Fraser HM, Konrad R, Holzheu I, Kreienberg R, Wulff C. HCG Controls luteal Vascular Permeability via VEGF by Down Regulation of a Cascade of Adhesion Proteins. Fert Ster submitted for publication.
9. E. Dejana, F. Orsenigo, C. Molendini, P. Baluk, and D.M. McDonald Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees Cell Tissue Res 335 2009 17 25
10. E. Dejana, E. Tournier-Lasserve, and B.M. Weinstein The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications Dev Cell 16 2009 209 221
11. M. Cavey, M. Rauzi, P.F. Lenne, and T. Lecuit A two-tiered mechanism for stabilization and immobilization of E-cadherin Nature 453 2008 751 756
12. N.A. Chitaev, and S.M. Troyanovsky Adhesive but not lateral E-cadherin complexes require calcium and catenins for their formation J Cell Biol 142 1998 837 846
13. W.J. Nelson, and P.J. Veshnock Ankyrin binding to (Na + + K +)ATPase and implications for the organization of membrane domains in polarized cells Nature 328 1987 533 536
14. A.S. Yap, W.M. Brieher, and B.M. Gumbiner Molecular and functional analysis of cadherin-based adherens junctions Annu Rev Cell Dev Biol 13 1997 119 146
15. T. Nitta, M. Hata, S. Gotoh, Y. Seo, H. Sasaki, and N. Hashimoto Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice J Cell Biol 161 2003 653 660
16. T. Groten, H.M. Fraser, W.C. Duncan, R. Konrad, R. Kreienberg, and C. Wulff Cell junctional proteins in the human corpus luteum: changes during the normal cycle and after HCG treatment Hum Reprod 21 2006 3096 3102
17. J. Neulen, Z. Yan, S. Raczek, K. Weindel, C. Keck, and H.A. Weich Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome J Clin Endocrinol Metab 80 1995 1967 1971
18. J. Neulen, S. Raczek, M. Pogorzelski, K. Grunwald, T.K. Yeo, and H.F. Dvorak Secretion of vascular endothelial growth factor/vascular permeability factor from human luteinized granulosa cells is human chorionic gonadotrophin dependent Mol Hum Reprod 4 1998 203 206
19. C. Wulff, H. Wilson, P. Largue, W.C. Duncan, D.G. Armstrong, and H.M. Fraser Angiogenesis in the human corpus luteum: localization and changes in angiopoietins, Tie-2 and vascular endothelial growth factor messenger ribonucleic acid J Clin Endocrinol Metab 85 2000 4302 4309
20. H.F. Dvorak, J.A. Nagy, D. Feng, L.F. Brown, and A.M. Dvorak Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis Curr Top Microbiol Immunol 237 1999 97 132
21. H.F. Dvorak Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy J Clin Oncol 20 2002 4368 4380
22. S. Esser, M.G. Lampugnani, M. Corada, E. Dejana, and W. Risau Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells J Cell Sci 111 1998 1853 1865
23. M. Rodewald, D. Herr, W.C. Duncan, H.M. Fraser, G. Hack, and R. Konrad Molecular mechanisms of ovarian hyperstimulation syndrome: paracrine reduction of endothelial claudin 5 by hCG in vitro is associated with increased endothelial permeability Hum Reprod 24 2009 1191 1199
24. D.R. Senger, L. Van de Water, and L.F. Brown Vascular permeability factor (VPF, VEGF) in tumor biology Cancer Metastasis Rev 12 1993 303 324
25. T.A. Olson, D. Mohanraj, L.F. Carson, and S. Ramakrishnan Vascular permeability factor gene expression in normal and neoplastic human ovaries Cancer Res 54 1994 276 280
26. S. Yamamoto, I. Konishi, M. Mandai, H. Kuroda, T. Komatsu, and K. Nanbu Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels Br J Cancer 76 1997 1221 1227
27. D. Hazelton, R.F. Nicosia, and S.V. Nicosia Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy Clin Cancer Res 5 1999 823 829
28. S. Yamamoto, I. Konishi, M. Mandai, H. Kuroda, T. Komatsu, and K. Nanbu Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels Br J Cancer 76 9 1997 1221 1227
29. B.C. Cooper, J.M. Ritchie, C.L. Broghammer, J. Coffin, J.I. Sorosky, and R.E. Buller Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer Clin Cancer Res 8 10 2002 Oct 3193 3197
30. R.G. Abell The permeability of blood capillary sprouts and newly formed blood capillaries as compared to that of older blood capillaries Am J Physiol 147 1946 237 241
31. R. Futami, M. Miyashita, T. Nomura, H. Makino, T. Matsutani, and K. Sasajima Increased serum vascular endothelial growth factor following major surgical injury J Nippon Med Sch 74 2007 223 229
32. C. Justinger, C. Schluter, V. Oliviera-Frick, B. Kopp, C. Rubie, and M.K. Schilling Increased growth factor expression after hepatic and pancreatic resection Oncol Rep 20 2008 1527 1531
33. W.L. Monsky, D. Fukumura, T. Gohongi, M. Ancukiewcz, H.A. Weich, and V.P. Torchilin Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor Cancer Res 59 16 1999 Aug 15 4129 4135
34. J.A. Nagy, E.M. Masse, K.T. Herzberg, M.S. Meyers, K.T. Yeo, and T.K. Yeo Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation Cancer Res 55 1995 360 368
35. C.A. Hamilton, G.L. Maxwell, M.R. Chernofsky, S.A. Bernstein, J.H. Farley, and G.S. Rose Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer Gynecol Oncol 111 3 2008 Dec 530 532 Epub 2008 Jun 18